Abivax (ABVX) Shares Outstanding (Diluted Average) (2021 - 2026)

Abivax's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $92.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 38.66% year-over-year to $92.4 million; the TTM figure through Mar 2026 stood at $92.4 million (up 38.66% YoY), while the FY2025 annual figure was $80.9 million, up 20.13% from the prior year.
• Shares Outstanding (Diluted Average) was $92.4 million for Q1 2026 at Abivax, up from $80.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $92.4 million in Q1 2026 to a low of $1400.0 in Q2 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $47.9 million across 5 years, with a median of $66.7 million in 2025.
• Biggest YoY gain for Shares Outstanding (Diluted Average) was 3578205.71% in 2025; the steepest drop was 2.46% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $19.5 million in 2022, then jumped by 137.88% to $46.3 million in 2023, then jumped by 45.4% to $67.4 million in 2024, then grew by 20.13% to $80.9 million in 2025, then grew by 14.22% to $92.4 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $92.4 million (Q1 2026), $80.9 million (Q4 2025), and $85.3 million (Q3 2025), per Business Quant data.